Register information Protection certificate

DE file number : 12 2019 000 102.6 (Status: not pending/lapsed, Query started: April 28, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTNot pending/lapsed
21DE file number DAKZ12 2019 000 102.6
UseVZMedicinal products
95Product nameTIEZEverolimus
54Title of basic patentTIGZRAPAMYCIN-DERIVAT ZUR BEHANDLUNG EINES SOLIDEN TUMORS, DER MIT DEREGULIERTER ANGIOGENESE ASSOZIIERT IST
51IPC main classICM
(ICMV)		 A61K 31/436 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61P 35/00 (2006.01), A61P 35/04 (2006.01)
94Start of term of protectionLBFeb 19, 2022
22DE application dateDATNov 21, 2019
Date of publication of application for a certificateOTMar 5, 2020
71/73Applicant/ownerINHNovartis Pharma AG, Lichtstr. 35, 4056 Basel, CH
74RepresentativeVTRBreuer, Markus, Dr., 80331 München, DE
Address for service Breuer Friedrich Hahner Patentanwälte PartG mbB, 80333 München, DE
Patent division in charge 44
68DE file number of basic patentGAKZ602 49 915.1
68EP file number of basic patentGEAKZ18 15 5644.0
43Date of first publicationEVTMar 5, 2020
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/09/538/001-008
2012-07-23
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/09/538/001-008
2012-07-23
Date of the first transfer into DPMAregisterEREGTMar 5, 2020
Date of the (most recent) update in DPMAregisterREGTAug 9, 2024
(Show all update days)(Hide all update days)
  • Aug 9, 2024
    • Representative: changed
  • Apr 30, 2022; Oct 13, 2020; Sep 23, 2020; Jun 26, 2020
    • Historical data not available for this/these date(s)
  • Mar 5, 2020
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Jan 28, 2020 Mar 5, 2020 Details anzeigen
2 New applicant/owner details New applicant/owner details Jun 25, 2020  Details anzeigen
3 Supplementary protection certificate procedure The application was withdrawn/the IP right was waived Sep 21, 2020 Oct 29, 2020 Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTJan 28, 2020
Issue numberHN10
YearPJ2020
Publication dateVTMar 5, 2020
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ602 49 915.1
68EP file number of basic patentGEAKZ18 15 5644.0
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 25, 2020
71/73Applicant/ownerINHNovartis Pharma AG, 4056 Basel, CH
71/73Previous applicant/ownerINHFNovartis International Pharmaceutical AG, 4056 Basel, CH, Novartis Pharma AG, 4056 Basel, CH
View procedures Supplementary protection certificate procedure (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTThe application was withdrawn/the IP right was waived
Date of legal/procedural statusVSTTSep 21, 2020
Issue numberHN44
YearPJ2020
Publication dateVTOct 29, 2020
Type of publicationPARTBibliographic data
PartHTPart 7
Date of update of the procedureREGTOct 13, 2020